Moderna
MRNA
#1020
Rank
โ‚ฌ17.94 B
Marketcap
46,62ย โ‚ฌ
Share price
-2.95%
Change (1 day)
-32.30%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Net assets

Net assets on the balance sheet as of June 2024 : โ‚ฌ10.86 Billion

According to Moderna 's latest financial reports the company has โ‚ฌ10.86 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Moderna - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$โ‚ฌ12.53 B-29.7%
2022-12-31$โ‚ฌ17.82 B42.73%
2021-12-31$โ‚ฌ12.49 B499.87%
2020-12-31$โ‚ฌ2.08 B98.54%
2019-12-31$โ‚ฌ1.04 B-21.6%
2018-12-31$โ‚ฌ1.33 B156.67%
2017-12-31$โ‚ฌ0.52 B-34.89%
2016-12-31$โ‚ฌ0.80 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚ฌ91.04 M-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ40.47 B 272.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ33.75 Million-100.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ30 M-99.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ40.28 B 270.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ0.31 B-97.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ65.05 B 499.03%๐Ÿ‡บ๐Ÿ‡ธ USA